Trials / Terminated
TerminatedNCT03307993
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
Interventional, Open-label, Positron Emission Tomography (PET) Study Investigating the Brain Receptor Occupancy of Idalopirdine in Patients With Alzheimer's Disease
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the brain receptor occupancy of idalopirdine in patients with Alzheimer's disease (AD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Idalopirdine | Idalopirdine 60-120 mg daily dose |
Timeline
- Start date
- 2017-09-22
- Primary completion
- 2018-02-19
- Completion
- 2018-02-19
- First posted
- 2017-10-12
- Last updated
- 2018-04-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03307993. Inclusion in this directory is not an endorsement.